Actively Recruiting

Age: 6Years - 23Years
All Genders
Healthy Volunteers
NCT03115710

The K-Map Study, Global Prevalence of KC

Led by University Hospital, Geneva · Updated on 2025-08-11

20000

Participants Needed

12

Research Sites

735 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Geneva

Lead Sponsor

E

ELZA Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

Keratoconus is a ocular disease classified under ectatic diseases which often results in bilateral and asymmetrical corneal distortion. It usually affects patients at young age and can cause severe visual loss. The overall goal of this study is to assess the prevalence of keratoconus (KC) in children and adolescents in various regions of the world based on modern tomographic imaging methods, and to verify whether the occurrence rates reported from literature should be corrected. Our hypothesis is that the prevalence of the disease is much higher than that traditionally reported. At each site, corneal tomography examinations (Pentacam) will be performed bilaterally in children and adolescents, who are not ill or with any ophthalmological symptom. The population to be studied will be composed of children and adolescents on medical visits for non-ophthalmologic reasons, aged between 6 and 20 years. Multiple cities, from different continents (North America, South America, Asia and Europe) will participate.

CONDITIONS

Official Title

The K-Map Study, Global Prevalence of KC

Who Can Participate

Age: 6Years - 23Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female, 6-23 years of age
  • Subjects seen for a non-ophthalmic appointment
  • Provide signed and dated patient consent form (signed by parents / legal guardians)
  • Willing to comply with all study procedures and be available for the duration of the study
Not Eligible

You will not qualify if you...

  • Patients with a preexisting ocular disease / condition
  • Pregnancy or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 12 locations

1

USC Roski Eye Institute

Los Angeles, California, United States, 90033

Actively Recruiting

2

Eye Hospital of Wenzhou Medical College

Wenzhou, China

Actively Recruiting

3

Zagreb, Croatia

Actively Recruiting

4

Alexandria, Egypt

Actively Recruiting

5

Homburg, Germany

Actively Recruiting

6

Isfahan, Iran

Actively Recruiting

7

Amman, Jordan

Actively Recruiting

8

Monterrey, Mexico

Actively Recruiting

9

Lima, Peru

Actively Recruiting

10

Ufa Eye Research Intitute

Ufa, Russia

Completed

11

King Saud University

Riyadh, Saudi Arabia

Completed

12

Bukhara, Uzbekistan

Actively Recruiting

Loading map...

Research Team

F

Farhad Hafezi, MDPhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here